MedPath

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Not Applicable
Recruiting
Conditions
HPV-Related Carcinoma
HPV Infection
Registration Number
NCT06574087
Lead Sponsor
PCK Marine Hospital in Gdynia
Brief Summary

The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
248
Inclusion Criteria
  • HPV related gynecological disease confirmed in histo-pathological examination
  • the posibility to obtain material from gynecological organ and from anal canal
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Anal intraepithelial neoplasm/ anal cancerJust before surgery

Number of Participants with anal intraepithelial neoplasm/ anal cancer among patients with HPV-related gynecological diseases.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PCK Marine Hospital in Gdynia

🇵🇱

Gdynia, Pomorskie, Poland

PCK Marine Hospital in Gdynia
🇵🇱Gdynia, Pomorskie, Poland
Michał Brzeziński
Principal Investigator
Maciej Stukan
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.